{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T00:13:29Z","timestamp":1789690409580,"version":"4.0.1"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012547","name":"Natural Science Foundation of Guangxi Zhuang Autonomous Region","doi-asserted-by":"publisher","award":["2025GXNSFHA069034"],"award-info":[{"award-number":["2025GXNSFHA069034"]}],"id":[{"id":"10.13039\/100012547","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Non-coding RNA Research"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ncrna.2026.07.001","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:53:02Z","timestamp":1786135982000},"page":"86-103","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Crosstalk between alternative splicing and non-coding RNAs in hepatocellular carcinoma: from regulatory mechanism to therapeutic implications"],"prefix":"10.1016","volume":"20","author":[{"given":"Delong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-3358-6276","authenticated-orcid":false,"given":"Jingli","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangxiu","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ncrna.2026.07.001_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J. Clin."},{"issue":"3","key":"10.1016\/j.ncrna.2026.07.001_bib2","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1007\/s11596-025-00064-w","article-title":"Global and country-level analysis of liver cancer: disease burden and recent trends","volume":"45","author":"Chen","year":"2025","journal-title":"Curr Med Sci"},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ncrna.2026.07.001_bib4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.canlet.2020.02.003","article-title":"Hepatocellular carcinoma-derived exosomes in organotropic metastasis, recurrence and early diagnosis application","volume":"477","author":"Ge","year":"2020","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.ncrna.2026.07.001_bib5","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1245\/s10434-016-5713-2","article-title":"Actual 10-Year survivors after resection of hepatocellular carcinoma","volume":"24","author":"Zheng","year":"2017","journal-title":"Ann. Surg Oncol."},{"issue":"19","key":"10.1016\/j.ncrna.2026.07.001_bib6","doi-asserted-by":"crossref","first-page":"17691","DOI":"10.1007\/s00432-023-05474-8","article-title":"Decoding the role of aberrant RNA alternative splicing in hepatocellular carcinoma: a comprehensive review","volume":"149","author":"Sheng","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"8","key":"10.1016\/j.ncrna.2026.07.001_bib7","doi-asserted-by":"crossref","first-page":"929","DOI":"10.3390\/cells8080929","article-title":"The intricate interplay between epigenetic events, alternative splicing and noncoding RNA deregulation in colorectal cancer","volume":"8","author":"Amirkhah","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ncrna.2026.07.001_bib8","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1146\/annurev.biochem.72.121801.161720","article-title":"Mechanisms of alternative pre-messenger RNA splicing","volume":"72","author":"Black","year":"2003","journal-title":"Annu. Rev. Biochem."},{"issue":"7515","key":"10.1016\/j.ncrna.2026.07.001_bib9","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nature13424","article-title":"Comparative analysis of the transcriptome across distant species","volume":"512","author":"Gerstein","year":"2014","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib10","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000838","article-title":"The alternative splicing landscape of hepatocellular carcinoma and its potential for HCC detection","volume":"10","author":"Hershberger","year":"2025","journal-title":"Hepatol. Commun."},{"key":"10.1016\/j.ncrna.2026.07.001_bib11","article-title":"Alternative splicing immune signature for detecting HBV-related hepatocellular carcinoma in peripheral blood mononuclear cells","volume":"44","author":"Daniels","year":"2025","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.ncrna.2026.07.001_bib12","article-title":"Inhibition of the U12-type splicing factor ZCRB1 mediates retention of the USP21 minor intron to suppress malignant progression in hepatocellular carcinoma","volume":"19","author":"Zhang","year":"2025","journal-title":"Hepatol. Int."},{"issue":"58","key":"10.1016\/j.ncrna.2026.07.001_bib32","doi-asserted-by":"crossref","first-page":"97835","DOI":"10.18632\/oncotarget.18279","article-title":"LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma","volume":"8","author":"Hu","year":"2017","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.ncrna.2026.07.001_bib33","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1007\/s12094-019-02223-7","article-title":"Long noncoding RNA CASC2c inhibited cell proliferation in hepatocellular carcinoma by inactivated ERK1\/2 and Wnt\/\u03b2-catenin signaling pathway","volume":"22","author":"Li","year":"2020","journal-title":"Clin. Transl. Oncol."},{"issue":"7","key":"10.1016\/j.ncrna.2026.07.001_bib36","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/ncb3538","article-title":"The MBNL3 splicing factor promotes hepatocellular carcinoma by increasing PXN expression through the alternative splicing of lncRNA-PXN-AS1","volume":"19","author":"Yuan","year":"2017","journal-title":"Nat. Cell Biol."},{"issue":"4","key":"10.1016\/j.ncrna.2026.07.001_bib37","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/hep.32195","article-title":"DDX17-regulated alternative splicing that produced an oncogenic isoform of PXN-AS1 to promote HCC metastasis","volume":"75","author":"Zhou","year":"2022","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/03008916211072585","article-title":"Alternatively-spliced lncRNA-PNUTS promotes HCC cell EMT via regulating ZEB1 expression","volume":"109","author":"Zhao","year":"2023","journal-title":"Tumori"},{"key":"10.1016\/j.ncrna.2026.07.001_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2022.102546","article-title":"HDLBP-stabilized lncFAL inhibits ferroptosis vulnerability by diminishing Trim69-dependent FSP1 degradation in hepatocellular carcinoma","volume":"58","author":"Yuan","year":"2022","journal-title":"Redox Biol."},{"key":"10.1016\/j.ncrna.2026.07.001_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216442","article-title":"Hypoxia-induced circ-CDYL-EEF1A2 transcriptional complex drives lung metastasis of cancer stem cells from hepatocellular carcinoma","volume":"578","author":"Kong","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ncrna.2026.07.001_bib56","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.omto.2022.02.021","article-title":"CircRHBDD1 augments metabolic rewiring and restricts immunotherapy efficacy via m6A modification in hepatocellular carcinoma","volume":"24","author":"Cai","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"issue":"4","key":"10.1016\/j.ncrna.2026.07.001_bib57","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/s41419-021-03626-7","article-title":"Circular RNA hsa_circ_101555 promotes hepatocellular carcinoma cell proliferation and migration by sponging miR-145-5p and regulating CDCA3 expression","volume":"12","author":"Gu","year":"2021","journal-title":"Cell Death Dis."},{"issue":"7","key":"10.1016\/j.ncrna.2026.07.001_bib58","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1158\/0008-5472.CAN-18-2238","article-title":"YY1 complex promotes quaking expression via super-enhancer binding during EMT of hepatocellular carcinoma","volume":"79","author":"Han","year":"2019","journal-title":"Cancer Res."},{"issue":"4","key":"10.1016\/j.ncrna.2026.07.001_bib59","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1158\/0008-5472.CAN-24-1630","article-title":"Energy stress-induced circEPB41(2) promotes lipogenesis in hepatocellular carcinoma","volume":"85","author":"Yang","year":"2025","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.ncrna.2026.07.001_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111707","article-title":"circPRKAA1 activates a Ku80\/Ku70\/SREBP-1 axis driving de novo fatty acid synthesis in cancer cells","volume":"41","author":"Li","year":"2022","journal-title":"Cell Rep."},{"issue":"12","key":"10.1016\/j.ncrna.2026.07.001_bib61","doi-asserted-by":"crossref","first-page":"3526","DOI":"10.7150\/thno.32796","article-title":"Circular RNAs negatively regulate cancer stem cells by physically binding FMRP against CCAR1 complex in hepatocellular carcinoma","volume":"9","author":"Zhu","year":"2019","journal-title":"Theranostics"},{"issue":"4","key":"10.1016\/j.ncrna.2026.07.001_bib62","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/s41388-019-1030-0","article-title":"NUDT21 regulates circRNA cyclization and ceRNA crosstalk in hepatocellular carcinoma","volume":"39","author":"Li","year":"2020","journal-title":"Oncogene"},{"issue":"4","key":"10.1016\/j.ncrna.2026.07.001_bib63","article-title":"Circ-MALAT1 functions as both an mRNA translation brake and a microRNA sponge to promote self-renewal of hepatocellular cancer stem cells","volume":"7","author":"Chen","year":"2019","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"16","key":"10.1016\/j.ncrna.2026.07.001_bib64","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.3390\/cancers15164057","article-title":"CPSF3 promotes Pre-mRNA splicing and prevents CircRNA cyclization in hepatocellular carcinoma","volume":"15","author":"Huang","year":"2023","journal-title":"Cancers (Basel)"},{"issue":"2","key":"10.1016\/j.ncrna.2026.07.001_bib65","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/iub.2438","article-title":"N6 -methyladenosine modification of circular RNA circ-ARL3 facilitates Hepatitis B virus-associated hepatocellular carcinoma via sponging miR-1305","volume":"73","author":"Rao","year":"2021","journal-title":"IUBMB Life"},{"issue":"8","key":"10.1016\/j.ncrna.2026.07.001_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1008346","article-title":"Host-derived circular RNAs display proviral activities in hepatitis C virus-infected cells","volume":"16","author":"Chen","year":"2020","journal-title":"PLoS Pathog."},{"issue":"36","key":"10.1016\/j.ncrna.2026.07.001_bib72","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1038\/onc.2015.517","article-title":"Splicing regulator SLU7 preserves survival of hepatocellular carcinoma cells and other solid tumors via oncogenic miR-17-92 cluster expression","volume":"35","author":"Urtasun","year":"2016","journal-title":"Oncogene"},{"issue":"13","key":"10.1016\/j.ncrna.2026.07.001_bib91","article-title":"A novel tRF, HCETSR, derived from tRNA-Glu\/TTC, inhibits HCC malignancy by regulating the SPBTN1-catenin complex axis","volume":"12","author":"Rui","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"51","key":"10.1016\/j.ncrna.2026.07.001_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abq7289","article-title":"MALAT1 modulates alternative splicing by cooperating with the splicing factors PTBP1 and PSF","volume":"8","author":"Miao","year":"2022","journal-title":"Sci. Adv."},{"issue":"24","key":"10.1016\/j.ncrna.2026.07.001_bib41","doi-asserted-by":"crossref","first-page":"4080","DOI":"10.1158\/0008-5472.CAN-23-0544","article-title":"Super enhancer-regulated LncRNA LINC01089 induces alternative splicing of DIAPH3 to drive hepatocellular carcinoma metastasis","volume":"83","author":"Su","year":"2023","journal-title":"Cancer Res."},{"key":"10.1016\/j.ncrna.2026.07.001_bib49","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.jare.2025.02.035","article-title":"Long non-coding RNA LINC01532 sustains redox homeostasis and accelerates lenvatinib resistance in hepatocellular carcinoma","volume":"78","author":"Hu","year":"2025","journal-title":"J. Adv. Res."},{"issue":"28","key":"10.1016\/j.ncrna.2026.07.001_bib42","doi-asserted-by":"crossref","first-page":"4675","DOI":"10.1038\/s41388-021-01905-3","article-title":"LINC01348 suppresses hepatocellular carcinoma metastasis through inhibition of SF3B3-mediated EZH2 pre-mRNA splicing","volume":"40","author":"Lin","year":"2021","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1186\/s13046-025-03546-w","article-title":"A novel lncRNA-mediated signaling axis governs cancer stemness and splicing reprogramming in hepatocellular carcinoma with therapeutic potential","volume":"44","author":"Si","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ncrna.2026.07.001_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217088","article-title":"LTR retrotransposon-derived LncRNA LINC01446 promotes hepatocellular carcinoma progression and angiogenesis by regulating the SRPK2\/SRSF1\/VEGF axis","volume":"598","author":"Wu","year":"2024","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.ncrna.2026.07.001_bib44","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1158\/0008-5472.CAN-16-1508","article-title":"Long noncoding RNA MALAT1 promotes hepatocellular carcinoma development by SRSF1 upregulation and mTOR activation","volume":"77","author":"Malakar","year":"2017","journal-title":"Cancer Res."},{"issue":"6","key":"10.1016\/j.ncrna.2026.07.001_bib45","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1002\/mc.23709","article-title":"Alternative splicing-related long noncoding RNA ANRIL facilitates hepatocellular carcinoma by targeting the miR-199a-5p\/SRSF1 axis and impacting anillin","volume":"63","author":"Zhang","year":"2024","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.ncrna.2026.07.001_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtherbio.2025.104174","article-title":"Exosomal CLRN1-AS1 restrains hepatocellular carcinoma cell proliferation and migration via targeting miR-320c\/SRSF7 signaling by using cellular thermal and medical thermal imaging","volume":"131","author":"Hao","year":"2025","journal-title":"J. Therm. Biol."},{"issue":"12","key":"10.1016\/j.ncrna.2026.07.001_bib46","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1111\/jgh.16735","article-title":"RNA-binding protein trx regulates alternative splicing and promotes metastasis of HCC via interacting with LINC00152","volume":"39","author":"Teng","year":"2024","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-53944-2","article-title":"Myc\/max dependent intronic long antisense noncoding RNA, EVA1A-AS, suppresses the expression of myc\/max dependent anti-proliferating gene EVA1A in a U2 dependent manner","volume":"9","author":"Niehus","year":"2019","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.ncrna.2026.07.001_bib70","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.23646","article-title":"SCARB1-encoded circ _0029343 induces p73 splicing to promote growth and metastasis of hepatocellular carcinoma via miR-486-5p\/SRSF3 axis","volume":"38","author":"Zhu","year":"2024","journal-title":"J. Biochem. Mol. Toxicol."},{"issue":"8","key":"10.1016\/j.ncrna.2026.07.001_bib74","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1074\/jbc.M111.291229","article-title":"DNA methylation-regulated miR-193a-3p dictates resistance of hepatocellular carcinoma to 5-fluorouracil via repression of SRSF2 expression","volume":"287","author":"Ma","year":"2012","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib75","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1038\/s41467-022-29016-x","article-title":"The aberrant upregulation of exon 10-inclusive SREK1 through SRSF10 acts as an oncogenic driver in human hepatocellular carcinoma","volume":"13","author":"Chang","year":"2022","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.ncrna.2026.07.001_bib29","first-page":"765","article-title":"MiR-374b re-sensitizes hepatocellular carcinoma cells to sorafenib therapy by antagonizing PKM2-mediated glycolysis pathway","volume":"9","author":"Zhang","year":"2019","journal-title":"Am. J. Cancer Res."},{"key":"10.1016\/j.ncrna.2026.07.001_bib76","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ebiom.2018.10.067","article-title":"SF3B4 is regulated by microRNA-133b and promotes cell proliferation and metastasis in hepatocellular carcinoma","volume":"38","author":"Liu","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.ncrna.2026.07.001_bib77","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2147\/JHC.S408542","article-title":"The role of miR-1183: a potential suppressor in hepatocellular carcinoma via regulating splicing factor SRSF1","volume":"10","author":"Yao","year":"2023","journal-title":"J. Hepatocell. Carcinoma"},{"issue":"24","key":"10.1016\/j.ncrna.2026.07.001_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e39909","article-title":"Bioinformatics in vivo and in vitro assays identified miR-486-5p as a tumor suppressor miRNA in hepatocellular carcinoma","volume":"10","author":"Li","year":"2024","journal-title":"Heliyon"},{"issue":"4","key":"10.1016\/j.ncrna.2026.07.001_bib13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1101\/gad.1048803","article-title":"Pre-mRNA splicing and human disease","volume":"17","author":"Faustino","year":"2003","journal-title":"Genes Dev."},{"key":"10.1016\/j.ncrna.2026.07.001_bib14","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1146\/annurev-biochem-013118-111024","article-title":"How is precursor messenger RNA spliced by the spliceosome?","volume":"89","author":"Wan","year":"2020","journal-title":"Annu. Rev. Biochem."},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib15","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1186\/s12885-022-10311-1","article-title":"Oncogenic KRAS alters splicing factor phosphorylation and alternative splicing in lung cancer","volume":"22","author":"Lo","year":"2022","journal-title":"BMC Cancer"},{"issue":"3","key":"10.1016\/j.ncrna.2026.07.001_bib16","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/humupd\/dmae037","article-title":"Defects in mRNA splicing and implications for infertility: a comprehensive review and in silico analysis","volume":"31","author":"Li","year":"2025","journal-title":"Hum. Reprod. Update"},{"issue":"5","key":"10.1016\/j.ncrna.2026.07.001_bib17","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1261\/rna.876308","article-title":"Splicing regulation: from a parts list of regulatory elements to an integrated splicing code","volume":"14","author":"Wang","year":"2008","journal-title":"RNA"},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/wrna.100","article-title":"Evolution of SR protein and hnRNP splicing regulatory factors","volume":"3","author":"Busch","year":"2012","journal-title":"Wiley Interdiscip. Rev. RNA"},{"issue":"3","key":"10.1016\/j.ncrna.2026.07.001_bib19","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1042\/BJ20100396","article-title":"Functional diversity of the hnRNPs: past, present and perspectives","volume":"430","author":"Han","year":"2010","journal-title":"Biochem. J."},{"key":"10.1016\/j.ncrna.2026.07.001_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217879","article-title":"CircSRPK1 mediated by the exon junction complex promotes gastric cancer progression by interacting with hnRNP A2B1 to regulate RON mRNA alternative splicing","volume":"629","author":"Yu","year":"2025","journal-title":"Cancer Lett."},{"issue":"12","key":"10.1016\/j.ncrna.2026.07.001_bib21","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.1038\/s42255-022-00681-y","article-title":"Liver RBFOX2 regulates cholesterol homeostasis via Scarb1 alternative splicing in mice","volume":"4","author":"Paterson","year":"2022","journal-title":"Nat. Metab."},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib22","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12920-025-02233-1","article-title":"Early alternative splicing signatures and RBP networks in MASLD progression to cirrhosis","volume":"18","author":"Chen","year":"2025","journal-title":"BMC Med Genomics"},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib23","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1038\/s41598-024-52237-7","article-title":"Dysregulation of RNA splicing in early non-alcoholic fatty liver disease through hepatocellular carcinoma","volume":"14","author":"Webster","year":"2024","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib24","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1186\/s12864-016-3029-z","article-title":"Global profiling of alternative RNA splicing events provides insights into molecular differences between various types of hepatocellular carcinoma","volume":"17","author":"Tremblay","year":"2016","journal-title":"BMC Genom."},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/hep.30158","article-title":"Transcriptome-wide analysis reveals the landscape of aberrant alternative splicing events in liver cancer","volume":"69","author":"Li","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib26","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s10020-021-00294-3","article-title":"Identification of prognostic alternative splicing events related to the immune microenvironment of hepatocellular carcinoma","volume":"27","author":"Yu","year":"2021","journal-title":"Mol Med"},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13046-025-03278-x","article-title":"SNORA37\/CMTR1\/ELAVL1 feedback loop drives gastric cancer progression via facilitating CD44 alternative splicing","volume":"44","author":"Bao","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.ncrna.2026.07.001_bib30","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1007\/s13402-025-01119-9","article-title":"Long non-coding RNA in hepatocellular carcinoma: mechanistic insights and therapeutic perspectives","volume":"48","author":"Yu","year":"2025","journal-title":"Cell. Oncol."},{"issue":"12","key":"10.1016\/j.ncrna.2026.07.001_bib31","doi-asserted-by":"crossref","first-page":"11843","DOI":"10.18632\/aging.103355","article-title":"Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma","volume":"12","author":"Yao","year":"2020","journal-title":"Aging (Albany NY)"},{"issue":"11","key":"10.1016\/j.ncrna.2026.07.001_bib34","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1080\/15476286.2021.1871816","article-title":"A chromatin-associated splicing isoform of OIP5-AS1 acts in cis to regulate the OIP5 oncogene","volume":"18","author":"Wanowska","year":"2021","journal-title":"RNA Biol."},{"issue":"11","key":"10.1016\/j.ncrna.2026.07.001_bib35","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1261\/rna.075309.120","article-title":"Antagonism between splicing and microprocessor complex dictates the serum-induced processing of lnc-MIRHG for efficient cell cycle reentry","volume":"26","author":"Sun","year":"2020","journal-title":"RNA"},{"key":"10.1016\/j.ncrna.2026.07.001_bib40","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3389\/fgene.2020.00659","article-title":"Comprehensive network analysis reveals alternative splicing-related lncRNAs in hepatocellular carcinoma","volume":"11","author":"Wang","year":"2020","journal-title":"Front. Genet."},{"issue":"Pt 1","key":"10.1016\/j.ncrna.2026.07.001_bib51","article-title":"Translatable circular RNAs: mechanism, function and clinical application","volume":"335","author":"Song","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib52","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1038\/s41467-022-31327-y","article-title":"Pervasive translation of circular RNAs driven by short IRES-like elements","volume":"13","author":"Fan","year":"2022","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib53","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s11658-024-00662-x","article-title":"The crosstalk between alternative splicing and circular RNA in cancer: pathogenic insights and therapeutic implications","volume":"29","author":"Hu","year":"2024","journal-title":"Cell. Mol. Biol. Lett."},{"issue":"14","key":"10.1016\/j.ncrna.2026.07.001_bib54","doi-asserted-by":"crossref","first-page":"7477","DOI":"10.3390\/ijms22147477","article-title":"Identification of novel RNA binding proteins influencing circular RNA expression in hepatocellular carcinoma","volume":"22","author":"Razpotnik","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ncrna.2026.07.001_bib69","article-title":"CircNSD2 promotes metastasis and immune escape by increasing the USP10\/SRSF6-mediated alternative splicing of TPM1 in TNBC","author":"Sun","year":"2026","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.ncrna.2026.07.001_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2025.101292","article-title":"Targeting CLK1\/SRSF7 axis-dependent alternative splicing sensitizes pancreatic ductal adenocarcinoma to chemotherapy and immunotherapy","volume":"83","author":"Zhang","year":"2025","journal-title":"Drug Resist Updat"},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib68","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12943-023-01912-w","article-title":"CircPPAP2B controls metastasis of clear cell renal cell carcinoma via HNRNPC-dependent alternative splicing and targeting the miR-182-5p\/CYP1B1 axis","volume":"23","author":"Zheng","year":"2024","journal-title":"Mol. Cancer"},{"issue":"17","key":"10.1016\/j.ncrna.2026.07.001_bib71","doi-asserted-by":"crossref","first-page":"8365","DOI":"10.3390\/ijms26178365","article-title":"Dysregulation of MicroRNAs in hepatocellular carcinoma: targeting oncogenic signaling pathways for innovative therapies","volume":"26","author":"Zarlashat","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.ncrna.2026.07.001_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0304947","article-title":"hnRNP Q\/SYNCRIP interacts with LIN28B and modulates the LIN28B\/let-7 axis in human hepatoma cells","volume":"19","author":"Chang","year":"2024","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.ncrna.2026.07.001_bib79","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/nar\/gkz1140","article-title":"Functional diversity of small nucleolar RNAs","volume":"48","author":"Bratkovi\u010d","year":"2020","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib80","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41420-021-00740-5","article-title":"Small nucleolar RNA 42 promotes the growth of hepatocellular carcinoma through the p53 signaling pathway","volume":"7","author":"Wang","year":"2021","journal-title":"Cell Death Discov."},{"issue":"9","key":"10.1016\/j.ncrna.2026.07.001_bib81","doi-asserted-by":"crossref","first-page":"13300","DOI":"10.18632\/aging.203014","article-title":"SnoRD126 promotes the proliferation of hepatocellular carcinoma cells through transcriptional regulation of FGFR2 activation in combination with hnRNPK","volume":"13","author":"Xu","year":"2021","journal-title":"Aging (Albany NY)"},{"issue":"20","key":"10.1016\/j.ncrna.2026.07.001_bib82","doi-asserted-by":"crossref","first-page":"9348","DOI":"10.7150\/thno.47677","article-title":"The C\/D box small nucleolar RNA SNORD52 regulated by Upf1 facilitates hepatocarcinogenesis by stabilizing CDK1","volume":"10","author":"Li","year":"2020","journal-title":"Theranostics"},{"issue":"26","key":"10.1016\/j.ncrna.2026.07.001_bib83","article-title":"SNORA74A drives self-renewal of liver cancer stem cells and hepatocarcinogenesis through activation of Notch3 signaling","volume":"12","author":"Zhou","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib84","doi-asserted-by":"crossref","first-page":"6730","DOI":"10.1038\/s41467-024-50987-6","article-title":"SNORD88B-mediated WRN nucleolar trafficking drives self-renewal in liver cancer initiating cells and hepatocarcinogenesis","volume":"15","author":"Gu","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.ncrna.2026.07.001_bib86","article-title":"Small nucleolar RNA SNORD13H suppresses tumor progression via FBL-dependent 2'-O-methylation in hepatocellular carcinoma","volume":"16","author":"Zhang","year":"2025","journal-title":"Front. Genet."},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib85","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1038\/s41467-025-66486-1","article-title":"SNORA49 negatively regulates self-renewal of liver cancer stem cells and hepatocarcinogenesis via suppressing SOX9 transcription","volume":"17","author":"Yi","year":"2026","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.ncrna.2026.07.001_bib87","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/j.jcmgh.2023.07.007","article-title":"Alternative splicing of lncRNAs from SNHG family alters snoRNA expression and induces chemoresistance in hepatoblastoma","volume":"16","author":"Zhen","year":"2023","journal-title":"Cell. Mol. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib88","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00018-025-05758-x","article-title":"SNORD88B promotes proliferation and invasion of trophoblast by regulating G3BP1 m6 A modification and alternative splicing","volume":"82","author":"Lu","year":"2025","journal-title":"Cell. Mol. Life Sci."},{"issue":"20","key":"10.1016\/j.ncrna.2026.07.001_bib89","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1111\/jcmm.17540","article-title":"SNORA70E promotes the occurrence and development of ovarian cancer through pseudouridylation modification of RAP1B and alternative splicing of PARPBP","volume":"26","author":"Chen","year":"2022","journal-title":"J. Cell Mol. Med."},{"issue":"4","key":"10.1016\/j.ncrna.2026.07.001_bib90","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1093\/nar\/gkad007","article-title":"The tRNA identity landscape for aminoacylation and beyond","volume":"51","author":"Gieg\u00e9","year":"2023","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib92","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/s41392-022-01003-0","article-title":"Role of main RNA modifications in cancer: N6-methyladenosine, 5-methylcytosine, and pseudouridine","volume":"7","author":"Xue","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib93","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12964-024-01595-w","article-title":"Clinical significance of RNA methylation in hepatocellular carcinoma","volume":"22","author":"Bao","year":"2024","journal-title":"Cell Commun. Signal."},{"issue":"10","key":"10.1016\/j.ncrna.2026.07.001_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108022","article-title":"N6-methyladenosine modification promotes hepatocarcinogenesis through circ-CDYL-enriched and EpCAM-positive liver tumor-initiating exosomes","volume":"26","author":"Wei","year":"2023","journal-title":"iScience"},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib95","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40364-023-00492-7","article-title":"Whole genome and RNA sequencing analyses for 254 Taiwanese hepatocellular carcinomas","volume":"11","author":"Chang","year":"2023","journal-title":"Biomark. Res."},{"key":"10.1016\/j.ncrna.2026.07.001_bib96","article-title":"Noncoding RNA as diagnostic and prognostic biomarkers in cerebrovascular disease","volume":"19","author":"Weng","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"6","key":"10.1016\/j.ncrna.2026.07.001_bib97","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3892\/br.2021.1426","article-title":"Screening for alternative splicing of lncRNA Dleu2 in the mouse liver cell line AML-12","volume":"14","author":"Kay","year":"2021","journal-title":"Biomed Rep"},{"issue":"10","key":"10.1016\/j.ncrna.2026.07.001_bib98","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1021\/acs.jafc.0c07640","article-title":"Kaempferol reverses aerobic glycolysis via miR-339-5p-Mediated PKM alternative splicing in Colon cancer cells","volume":"69","author":"Wu","year":"2021","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ncrna.2026.07.001_bib99","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.canlet.2020.10.010","article-title":"Splicing factor SF3B1 is overexpressed and implicated in the aggressiveness and survival of hepatocellular carcinoma","volume":"496","author":"L\u00f3pez-C\u00e1novas","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.ncrna.2026.07.001_bib100","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116251","article-title":"DDX39B protects against sorafenib-induced ferroptosis by facilitating the splicing and cytoplasmic export of GPX4 pre-mRNA in hepatocellular carcinoma","volume":"225","author":"Li","year":"2024","journal-title":"Biochem. Pharmacol."},{"issue":"51","key":"10.1016\/j.ncrna.2026.07.001_bib101","doi-asserted-by":"crossref","first-page":"48650","DOI":"10.1021\/acsomega.3c07618","article-title":"Evaluation of chemically modified nucleic acid analogues for splice switching application","volume":"8","author":"Le","year":"2023","journal-title":"ACS Omega"},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib102","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.molcel.2025.12.004","article-title":"Splice-switching ASOs targeting the AURKA 5' UTR collapse an SRSF1-AURKA-MYC oncogenic circuit in pancreatic cancer","volume":"86","author":"Kral","year":"2026","journal-title":"Mol Cell"},{"issue":"6","key":"10.1016\/j.ncrna.2026.07.001_bib103","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1038\/s41416-020-0951-2","article-title":"Targeting the ERG oncogene with splice-switching oligonucleotides as a novel therapeutic strategy in prostate cancer","volume":"123","author":"Li","year":"2020","journal-title":"Br. J. Cancer"},{"issue":"6","key":"10.1016\/j.ncrna.2026.07.001_bib104","doi-asserted-by":"crossref","first-page":"9000","DOI":"10.1021\/acsami.4c19340","article-title":"Accelerated endosomal escape of splice-switching oligonucleotides enables efficient hepatic splice correction","volume":"17","author":"Weiss","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"2","key":"10.1016\/j.ncrna.2026.07.001_bib105","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.jhep.2025.02.007","article-title":"Developing splice-switching oligonucleotides for urea cycle disorder using an integrated diagnostic and therapeutic platform","volume":"83","author":"Ow","year":"2025","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.ncrna.2026.07.001_bib106","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/s41576-022-00556-8","article-title":"Regulation of pre-mRNA splicing: roles in physiology and disease, and therapeutic prospects","volume":"24","author":"Rogalska","year":"2023","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.ncrna.2026.07.001_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2026.119025","article-title":"RNA splicing dysregulation in hepatocellular carcinoma: molecular mechanisms, therapeutic targets, and intervention strategies-A comprehensive review","volume":"195","author":"Xiong","year":"2026","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ncrna.2026.07.001_bib108","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2021.754709","article-title":"Advances in multi-omics applications in HBV-associated hepatocellular carcinoma","volume":"8","author":"Cui","year":"2021","journal-title":"Front. Med."},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib109","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1186\/s13059-020-02173-2","article-title":"Multiplex enCas12a screens detect functional buffering among paralogs otherwise masked in monogenic Cas9 knockout screens","volume":"21","author":"Dede","year":"2020","journal-title":"Genome Biol."},{"issue":"7691","key":"10.1016\/j.ncrna.2026.07.001_bib110","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature25461","article-title":"Enhancer redundancy provides phenotypic robustness in mammalian development","volume":"554","author":"Osterwalder","year":"2018","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ncrna.2026.07.001_bib111","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1011685","article-title":"Incomplete paralog compensation generates selective dependency on TRA2A in cancer","volume":"21","author":"Lee","year":"2025","journal-title":"PLoS Genet."},{"issue":"10","key":"10.1016\/j.ncrna.2026.07.001_bib112","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41573-020-0075-7","article-title":"Advances in oligonucleotide drug delivery","volume":"19","author":"Roberts","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"12","key":"10.1016\/j.ncrna.2026.07.001_bib113","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41578-021-00358-0","article-title":"Lipid nanoparticles for mRNA delivery","volume":"6","author":"Hou","year":"2021","journal-title":"Nat. Rev. Mater."},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib114","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s13046-025-03279-w","article-title":"Targeting RNA splicing modulation: new perspectives for anticancer strategy?","volume":"44","author":"Lv","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.ncrna.2026.07.001_bib115","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-45614-1","article-title":"Diet-induced rewiring of the wnt gene regulatory network connects aberrant splicing to fatty liver and liver cancer in DIAMOND mice","volume":"13","author":"L\u00f3pez-P\u00e9rez","year":"2023","journal-title":"Sci. Rep."}],"container-title":["Non-coding RNA Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054026000508?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468054026000508?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T23:39:10Z","timestamp":1789688350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468054026000508"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":115,"alternative-id":["S2468054026000508"],"URL":"https:\/\/doi.org\/10.1016\/j.ncrna.2026.07.001","relation":{},"ISSN":["2468-0540"],"issn-type":[{"value":"2468-0540","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Crosstalk between alternative splicing and non-coding RNAs in hepatocellular carcinoma: from regulatory mechanism to therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Non-coding RNA Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ncrna.2026.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}